Who owns NOVANTA INC (GSIGQ)? Elite investor 13F holders

4 tracked elite investors reported holding NOVANTA INC as of 2026-09-30, including D.E. Shaw, Bridgewater Associates, Gotham Asset Management, Torray Funds. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

4 tracked investors currently reported holding · Latest report period: 2026-09-30 · Industrials · Capital Goods

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
D.E. ShawNovanta Inc - USSHARE2026-09-302026-11-16 00:00:0029721383.00 USD490000.000000SharesholdOriginal filing
Bridgewater AssociatesNOVANTA INCSHARE2026-09-302026-11-16 00:00:0013556252.00 USD95339.000000SharesaddOriginal filing
Gotham Asset ManagementNOVANTA INCSHARE2026-09-302026-11-16 00:00:003308050.00 USD23265.000000SharesaddOriginal filing
D.E. ShawNOVANTA INCSHARE2026-09-302026-11-16 00:00:003238519.00 USD22776.000000SharesaddOriginal filing
Polen Capital ManagementNOVANTA INCSHARE2026-09-302026-11-13 00:00:000.00 USD0.000000SharesexitedOriginal filing
Torray FundsNOVANTA INCSHARE2026-09-302026-10-30 00:00:001952411.00 USD13731.000000SharesaddOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown